bLOG

Insights and strategies

Select by Category

Stay in the loop

Subscribe to our newsletter for the latest updates, product news, and more.

Competitive insights

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Elke Ydens

Associate Director of Business Solutions

Competitive insights

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Elke Ydens

Associate Director of Business Solutions

Competitive insights

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Elke Ydens

Associate Director of Business Solutions

Competitive insights

Rare disease

Same Trial Goals, Lean Team? TA Scan Picks Up the Slack

Elke Ydens

Associate Director of Business Solutions

Rare disease

Same Trial Goals, Lean Team? TA Scan Picks Up the Slack

Elke Ydens

Associate Director of Business Solutions

Rare disease

Same Trial Goals, Lean Team? TA Scan Picks Up the Slack

Elke Ydens

Associate Director of Business Solutions

Rare disease

Feasibility

Think All Trial Data Is the Same? Think Again.

Elke Ydens

Associate Director of Business Solutions

Feasibility

Think All Trial Data Is the Same? Think Again.

Elke Ydens

Associate Director of Business Solutions

Feasibility

Think All Trial Data Is the Same? Think Again.

Elke Ydens

Associate Director of Business Solutions

Feasibility

Clinical insights

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Elke Ydens

Associate Director of Business Solutions

Clinical insights

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Elke Ydens

Associate Director of Business Solutions

Clinical insights

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Elke Ydens

Associate Director of Business Solutions

Clinical insights

Competitive insights

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Elke Ydens

Associate Director of Business Solutions

Competitive insights

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Elke Ydens

Associate Director of Business Solutions

Competitive insights

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Elke Ydens

Associate Director of Business Solutions

Competitive insights

Site selection

The Strategic Role of KOLs in Rare Disease Drug Development

Elke Ydens

Associate Director of Business Solutions

Site selection

The Strategic Role of KOLs in Rare Disease Drug Development

Elke Ydens

Associate Director of Business Solutions

Site selection

The Strategic Role of KOLs in Rare Disease Drug Development

Elke Ydens

Associate Director of Business Solutions

Site selection

bLOG

bLOG

bLOG

Insights and strategies

Stay in the loop

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Same Trial Goals, Lean Team? TA Scan Picks Up the Slack

Same Trial Goals, Lean Team? TA Scan Picks Up the Slack

Same Trial Goals, Lean Team? TA Scan Picks Up the Slack

Think All Trial Data Is the Same? Think Again.

Think All Trial Data Is the Same? Think Again.

Think All Trial Data Is the Same? Think Again.

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

The Strategic Role of KOLs in Rare Disease Drug Development

The Strategic Role of KOLs in Rare Disease Drug Development

The Strategic Role of KOLs in Rare Disease Drug Development

Where data and expertise come together to plan smarter trials.

Where data and expertise come together to plan smarter trials.

Where data and expertise come together to plan smarter trials.

Stay in the loop

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Same Trial Goals, Lean Team? TA Scan Picks Up the Slack

Same Trial Goals, Lean Team? TA Scan Picks Up the Slack

Same Trial Goals, Lean Team? TA Scan Picks Up the Slack

Think All Trial Data Is the Same? Think Again.

Think All Trial Data Is the Same? Think Again.

Think All Trial Data Is the Same? Think Again.

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

The Strategic Role of KOLs in Rare Disease Drug Development

The Strategic Role of KOLs in Rare Disease Drug Development

The Strategic Role of KOLs in Rare Disease Drug Development

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition